ASPP2 suppression promotes malignancy via LSR and YAP in human endometrial cancer

[1]  Tsuyoshi Saito,et al.  Epithelial barrier dysfunction and cell migration induction via JNK/cofilin/actin by angubindin-1 , 2019, Tissue barriers.

[2]  Jing Wang,et al.  YAP promotes the malignancy of endometrial cancer cells via regulation of IL-6 and IL-11 , 2019, Molecular medicine.

[3]  L. Tang,et al.  A novel PAK4-CEBPB-CLDN4 axis involving in breast cancer cell migration and invasion. , 2019, Biochemical and biophysical research communications.

[4]  Do Hyung Kim,et al.  Claudin-7 modulates cell-matrix adhesion that controls cell migration, invasion and attachment of human HCC827 lung cancer cells , 2019, Oncology letters.

[5]  Wei Li,et al.  Overexpression of microRNA‐98 inhibits cell proliferation and promotes cell apoptosis via claudin‐1 in human colorectal carcinoma , 2018, Journal of cellular biochemistry.

[6]  Tao Yang,et al.  Downregulation of ASPP2 promotes gallbladder cancer metastasis and macrophage recruitment via aPKC-ι/GLI1 pathway , 2018, Cell Death & Disease.

[7]  Kunming Zhao,et al.  HDAC1-induced epigenetic silencing of ASPP2 promotes cell motility, tumour growth and drug resistance in renal cell carcinoma. , 2018, Cancer letters.

[8]  Tsuyoshi Saito,et al.  Downregulation of lipolysis-stimulated lipoprotein receptor promotes cell invasion via claudin-1-mediated matrix metalloproteinases in human endometrial cancer. , 2017, Oncology letters.

[9]  Takashi Kojima,et al.  Loss of tricellular tight junction protein LSR promotes cell invasion and migration via upregulation of TEAD1/AREG in human endometrial cancer , 2017, Scientific Reports.

[10]  Tsuyoshi Saito,et al.  The roles of tricellular tight junction protein lipolysis-stimulated lipoprotein receptor in malignancy of human endometrial cancer cells , 2016, Oncotarget.

[11]  Bin Zhao,et al.  Hippo Pathway in Organ Size Control, Tissue Homeostasis, and Cancer , 2015, Cell.

[12]  X. Matías-Guiu,et al.  A role for the transducer of the Hippo pathway, TAZ, in the development of aggressive types of endometrial cancer , 2015, Modern Pathology.

[13]  Xian-gui Hu,et al.  Downregulation of ASPP2 in pancreatic cancer cells contributes to increased resistance to gemcitabine through autophagy activation , 2015, Molecular Cancer.

[14]  S. Zhong,et al.  ASPP2 Links the Apical Lateral Polarity Complex to the Regulation of YAP Activity in Epithelial Cells , 2014, PloS one.

[15]  H. Moch,et al.  ASPP2 controls epithelial plasticity and inhibits metastasis through β-catenin-dependent regulation of ZEB1 , 2014, Nature Cell Biology.

[16]  M. Furuse,et al.  Tricellulin regulates junctional tension of epithelial cells at tricellular contacts through Cdc42 , 2014, Journal of Cell Science.

[17]  A. Friedler,et al.  Protein–protein interactions of ASPP2: an emerging therapeutic target , 2014 .

[18]  J. Kissil,et al.  The Angiomotins – From discovery to function , 2014, FEBS letters.

[19]  M. Furuse,et al.  Molecular organization of tricellular tight junctions , 2014, Tissue barriers.

[20]  H. Cai,et al.  HDAC as a therapeutic target for treatment of endometrial cancers. , 2014, Current pharmaceutical design.

[21]  David W. Scott,et al.  The Role of Lipolysis Stimulated Lipoprotein Receptor in Breast Cancer and Directing Breast Cancer Cell Behavior , 2014, PloS one.

[22]  Xin Lu,et al.  Phosphorylation of ASPP2 by RAS/MAPK Pathway Is Critical for Its Full Pro-Apoptotic Function , 2013, PloS one.

[23]  G. Bell,et al.  Lipolysis-stimulated lipoprotein receptor (LSR) is the host receptor for the binary toxin Clostridium difficile transferase (CDT) , 2011, Proceedings of the National Academy of Sciences.

[24]  H. Sasaki,et al.  LSR defines cell corners for tricellular tight junction formation in epithelial cells , 2011, Journal of Cell Science.

[25]  Zhen-xi Zhang,et al.  Expression Pattern of the ASPP Family Members in Endometrial Endometrioid Adenocarcinoma , 2010, Oncology Research and Treatment.

[26]  H. Hirano,et al.  ASPP2 Regulates Epithelial Cell Polarity through the PAR Complex , 2010, Current Biology.

[27]  Xin Lu,et al.  ASPP2 binds Par-3 and controls the polarity and proliferation of neural progenitors during CNS development. , 2010, Developmental cell.

[28]  Xin Lu,et al.  Epigenetic silence of ankyrin‐repeat–containing, SH3‐domain–containing, and proline‐rich‐region– containing protein 1 (ASPP1) and ASPP2 genes promotes tumor growth in hepatitis B virus–positive hepatocellular carcinoma , 2010, Hepatology.

[29]  Xin Lu,et al.  ASPP: a new family of oncogenes and tumour suppressor genes , 2007, British Journal of Cancer.

[30]  S. Tsukita,et al.  Tricellulin constitutes a novel barrier at tricellular contacts of epithelial cells , 2005, The Journal of cell biology.

[31]  Xin Lu,et al.  Downregulated mRNA expression of ASPP and the hypermethylation of the 5′‐untranslated region in cancer cell lines retaining wild‐type p53 , 2005, FEBS letters.

[32]  Y. Samuels,et al.  ASPP1 and ASPP2: Common Activators of p53 Family Members , 2004, Molecular and Cellular Biology.